公司資料
Zai Lab Limited 股價、新聞與催化劑
- 股票代碼:
- ZLAB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- China and listed in the U
股票表現
25.64 USD (-1.00%)
收盤價
最後更新: 2026年8月17日
1.93B USD
市值
股價為何變動
As of Aug 17, 2026, ZLAB closed down 1.00% at $25.64. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Zai Lab is a global biopharmaceutical company focused on oncology, infectious disease, and autoimmune disease. Its story combines commercial execution in Asia with a broad development pipeline and international reach.
所在地與產業分類
Zai Lab is headquartered in China and listed in the U.S. market. It sits in global specialty biopharma with a strong oncology footprint.
商業模式特徵
The company generates value through product commercialization, pipeline progress, and strategic partnerships across major therapeutic areas. Investors watch revenue growth, approvals, and portfolio expansion.
生技產業定位
Zai Lab occupies a top-tier global biopharma niche. It is more durable than a small-cap biotech name, but pipeline and commercial catalysts still matter a lot.
未來催化劑
- Zai Lab’s catalysts are oncology and immunology commercialization, plus any pipeline step that helps the company keep building a broader China-anchored biotech franchise. The stock moves on execution across multiple assets.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。